Human Data Can’t Wait for Clinical Trials.
3D HUMAN BIOLOGY-ON-A-CHIP FOR HUMANIZED DRUG DISCOVERY AND CLINICAL DECISION MAKING
Accelerating drug discovery with AIM Biotech’s humanized BioAvatar products & services.
From the most demanding basic research, to predictive screens for drug discovery, to the tailored selection of precision medicines, AIM Biotech enables and accelerates the development of cutting-edge therapeutics. This is made possible through AIM Biotech’s BioAvatar technology, which embodies our core expertise in the design and manufacture of sophisticated microfluidic systems and human tissue models. Our BioAvatars combine unmatched recapitulation of human biology with unparalleled ease-of-use, resulting in a powerful solution to move medicine forward.
Humanized pre-clinical insights for increased predictability of clinical outcomes
Acceleration of the drug discovery process through easy-to-implement humanized organ-on-a-chip models
Replacement of animal models in pre-clinical trials
Explore AIM Biotech Solutions for Humanized Drug Discovery and Functional Precision Medicine
Introducing organiX: specifically made for Organoids and Biopsies
organiX is a revolution in Human Tissue and Biopsy Culture for Functional Precision Medicine and Drug Discovery
Designed to enable drug discovery and targeted therapies in large tissue samples like biopsies, organoids, tumoroids, spheroids and tissue aggregates, organiX allows for the detailed recreation of tissue and tumor microenvironments that is missing from current organoid research.
The ability to create actual physiological context for the study of these larger tissue samples is what sets organiX apart.
organiX Plate - Human Tissue | Translated.
Amplify the power of organoid research and biopsy characterization with organiX
Culture – biopsies, organoids, tumor tumoroids, spheroids or any cell/tissue aggregate up to 2 mm in diameter
Contextualize – set assay conditions with perfusable vasculature, co-culture, signaling gradients and media flow for an in vivo-like tumor microenvironment (TME)
Extract – First, obtain real time high resolution imaging data and then easily extract tissue samples for downstream analysis
Level Up! – Now revolutionize your fully contextualized organoid research utilizing conventional immunohistochemistry and next generation technologies like Digital Spatial Profiling
Introducing idenTx for scalable, flexible organ-on-a-chip drug discovery
idenTx is the humanized 3D tissue culture platform for drug discovery
AIM Biotech’s idenTx line of 3D tissue culture chips and plates enable predictive human BioAvatars that recapitulate human microphysiology more accurately than traditional cell culture or animal models. Available in formats for 3, 9, and 40 parallel experiments, idenTx multiplies your throughput in alignment with your drug discovery programs.
Easy-to-use. Flexible. Scalable. idenTx enables human-focused, clinically-relevant results that accelerate the development of cutting-edge therapies.
Human biology-on-a-chip. Simplified.
idenTx 3 Chip
AIM Biotech’s proven 3D Cell Culture Chip, DAX-1
This is AIM Biotech’s proven 3D Cell Culture Chip, now part of the idenTx family. Designed in a microscope slide format, this most basic component of the idenTx family enables 3 simultaneous experiments. It is ideal for establishing experimental feasibility or for general low-throughput applications.
Human biology-on-a-chip. Standardized.
idenTx 9 Plate
Three fully-integrated idenTx 3 Chips enable 9 simultaneous experiments; scale up for introduction of plate-based robotics and automation.
Human biology-on-a-chip. Multiplied.
idenTx 40 Plate
Highest throughput plate option, enabling 40 simultaneous experiments to fully accelerate drug discovery through high-content screening.
Human Data. Experimental Simplicity.
Scalability without Compromise.
Unmatched ease-of-use: no special handling, no special training, no special hardware
Built in Scalability to take your research from feasibility to higher throughput screening
Your study. Our lab. Human data.
Contract research services for humanized, organ-on-a-chip studies
With AIM Biotech contract research services, increasing throughput while maintaining assay sophistication is our expertise. Our pharma-focused solutions combine speed and simplicity with the ability to model complex tissues that you expect from organ-on-a-chip assays.
Let AIM Biotech accelerate your drug discovery programs using our humanized BioAvatar Technology in our state-of-the-art research services lab. Our team can even work with you to design, develop, and execute custom assays to deliver human-focused, clinically-relevant results that move your drug discovery programs forward.
Custom assay development
Rapid humanized throughput
Functional immuno-oncology assays
Answer primary research questions
Data on routine screens
In-vitro organ models
Your path to predictive data and insightful diagnostics.
Simple-to-use, fully scalable microfluidic systems in plate and chip formats to recapitulate human physiology.
Validated protocols in T-cell efficiency, immunotherapies, cell migration, vasculogenesis and more
Custom assay development and higher-throughput, high-content screening with assays of your choice
Mechanism of action
In vitro screening
ADME toxicity studies
New application note with AIM Biotech and Nikon: Confocal Imaging of in vitro BBB model using idenTx platform
AIM Biotech and Nikon Instruments have produced a new application note demonstrating a robust and cost-effective way to assess neurotherapeutic drug transport and neurovascular function of the human blood brain barrier (BBB) in vitro. The human cell tri-culture BBB model results in a...
Webinar: Scaling-up Organ-on-chip Assays for drug discovery with AIM Biotech 3D Tissue Culture Systems and the Opentrons OT-2
In case you missed it, check out our recent webinar with our friends at Opentrons. AIM Biotech’s Sei Hein Lim talks about how to scale-up drug discovery research using AIM’s organiX and idenTx 3D tissue culture platforms in conjunction with the Opentrons OT-2 lab robot. The webinar will...
Ex vivo culture of human biopsies with idenTx: leveraging the STING pathway to complement NK-cell therapy
In a recent publication in Cancer Immunology Research, a team led by scientists at Dana-Farber Cancer Institute and Brigham and Women’s Hospital used AIM Biotech’s idenTx drug discovery platform to demonstrate the therapeutic potential of STING (stimulator of interferon genes) agonists in...